[Coagulation analysis in transplantation patients].
In patients post organ transplantation, the underlying disorder necessitating the transplantation, as well as the transplantation itself, can both mask pre-existing haemostatic abnormalities or lead to them. Since the liver is the main production site for coagulation factors, orthotopic liver transplantation predestinates for acquiring or losing a genetically determined coagulation defect. In coagulation diagnostics, this may lead to a discrepancy between functional plasma tests and molecular biologic findings if these are gathered from nucleated cells of the peripheral blood, as is the standard. Due to the rareness of most defects and the lack of consequences in case of diagnosis of a more common coagulation disorder, no general screening before or after transplantation is required. Underlying diseases leading to liver transplantation as well as the actual transplantation must be considered when interpreting the findings.
Loew
A
A
Charité Campus Virchow Klinikum, Augustenburgerplatz 1, 13353 Berlin. andreas.loew@charite.de
Riess
H
H
D001777:Blood Coagulation; D020141:Hemostatic Disorders / Q000097:blood / Q000150:complications; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000601:surgery; D016031:Liver Transplantation / Q000502:physiology; D016377:Organ Transplantation / Q000502:physiology; D018579:Patient Selection; D011300:Preoperative Care